Total Payments
$6,076
2024 Payments
$655.35
Companies
49
Transactions
279
Medicare Patients
2,144
Medicare Billing
$307,569
Payment Breakdown by Category
Food & Beverage$5,853 (96.3%)
Education$198.08 (3.3%)
Gifts$25.00 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,853 | 270 | 96.3% |
| Education | $198.08 | 8 | 3.3% |
| Gift | $25.00 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $834.72 | 25 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $514.54 | 30 | $0 (2024) |
| Janssen Biotech, Inc. | $499.37 | 32 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $357.79 | 15 | $0 (2021) |
| Merck Sharp & Dohme LLC | $304.37 | 23 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $285.74 | 11 | $0 (2024) |
| Celgene Corporation | $221.32 | 11 | $0 (2020) |
| Genentech USA, Inc. | $221.23 | 16 | $0 (2024) |
| PFIZER INC. | $192.30 | 13 | $0 (2024) |
| Ipsen Biopharmaceuticals, Inc | $169.33 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $655.35 | 25 | Intera Oncology, Inc ($95.72) |
| 2023 | $395.83 | 5 | Galvanize Therapeutics, Inc ($113.12) |
| 2022 | $268.16 | 5 | Ipsen Biopharmaceuticals, Inc ($121.01) |
| 2021 | $256.39 | 4 | AstraZeneca Pharmaceuticals LP ($120.46) |
| 2020 | $437.41 | 17 | Amgen Inc. ($144.79) |
| 2019 | $2,012 | 106 | Merck Sharp & Dohme Corporation ($196.05) |
| 2018 | $1,544 | 88 | Amgen Inc. ($221.36) |
| 2017 | $506.52 | 29 | Amgen Inc. ($125.90) |
All Payment Transactions
279 individual payment records from CMS Open Payments — Page 2 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2023 | Amgen Inc. | LUMAKRAS (Drug) | Food and Beverage | In-kind items and services | $95.40 | General |
| Category: Oncology | ||||||
| 12/05/2023 | Genentech USA, Inc. | Tecentriq (Biological) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: BioOncology | ||||||
| 11/21/2023 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $70.09 | General |
| Category: ONCOLOGY | ||||||
| 08/14/2023 | Galvanize Therapeutics, Inc | ALIYA SYSTEM (Device) | Food and Beverage | In-kind items and services | $113.12 | General |
| Category: PULSED ELECTRIC FIELD | ||||||
| 04/24/2023 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $102.21 | General |
| Category: Oncology | ||||||
| 12/12/2022 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $86.99 | General |
| 10/04/2022 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: Oncology | ||||||
| 09/06/2022 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Iron Deficiency Anemia | ||||||
| 08/31/2022 | Daiichi Sankyo Inc. | ENHERTU (Drug) | Food and Beverage | In-kind items and services | $28.87 | General |
| Category: ONCOLOGY | ||||||
| 08/04/2022 | Ipsen Biopharmaceuticals, Inc | ONIVYDE (Drug) | Food and Beverage | In-kind items and services | $121.01 | General |
| Category: Oncology | ||||||
| 07/20/2021 | Alexion Pharmaceuticals, Inc. | Ultomiris (Drug) | Education | In-kind items and services | $23.77 | General |
| Category: Immunology | ||||||
| 06/01/2021 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $120.46 | General |
| Category: Oncology | ||||||
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 03/23/2021 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $100.24 | General |
| Category: Oncology | ||||||
| 09/28/2020 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $90.04 | General |
| Category: Hematology/Oncology | ||||||
| 08/24/2020 | Amgen Inc. | Kyprolis (Drug) | Food and Beverage | In-kind items and services | $88.88 | General |
| Category: Oncology | ||||||
| 02/29/2020 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $33.93 | General |
| Category: Oncology | ||||||
| 02/24/2020 | Novartis Pharmaceuticals Corporation | PIQRAY (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: ONCOLOGY | ||||||
| 02/18/2020 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: ONCOLOGY | ||||||
| 02/13/2020 | Amgen Inc. | MVASI (Biological), Neulasta | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Oncology | ||||||
| 02/07/2020 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Oncology | ||||||
| 01/31/2020 | Novartis Pharmaceuticals Corporation | TASIGNA (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: ONCOLOGY | ||||||
| 01/30/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/24/2020 | E.R. Squibb & Sons, L.L.C. | INREBIC (Drug) | Food and Beverage | Cash or cash equivalent | $14.26 | General |
| Category: Hematology | ||||||
| 01/23/2020 | Amgen Inc. | Kyprolis (Drug) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 433 | 645 | $188,483 | $70,889 |
| 2022 | 10 | 496 | 756 | $181,433 | $76,117 |
| 2021 | 12 | 623 | 920 | $203,663 | $94,336 |
| 2020 | 13 | 592 | 788 | $168,272 | $66,228 |
Total Patients
2,144
Total Services
3,109
Medicare Billing
$307,569
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 139 | 281 | $96,383 | $36,375 | 37.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 144 | 189 | $45,927 | $16,533 | 36.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 61 | 61 | $25,681 | $9,766 | 38.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $7,632 | $2,910 | 38.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 16 | 25 | $4,975 | $2,290 | 46.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 23 | $3,956 | $1,362 | 34.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 12 | 17 | $2,329 | $1,037 | 44.5% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 16 | 25 | $1,600 | $616.44 | 38.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 152 | 315 | $92,505 | $40,319 | 43.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 134 | 170 | $36,718 | $15,143 | 41.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 43 | 43 | $17,323 | $7,113 | 41.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 45 | 47 | $7,244 | $3,093 | 42.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 23 | 34 | $6,794 | $2,618 | 38.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 23 | 23 | $6,017 | $2,287 | 38.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $5,024 | $1,769 | 35.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 19 | 33 | $4,567 | $1,722 | 37.7% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 25 | 51 | $3,825 | $1,439 | 37.6% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 16 | 24 | $1,416 | $612.68 | 43.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 128 | 289 | $78,897 | $38,950 | 49.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 141 | 185 | $37,370 | $17,369 | 46.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 47 | 80 | $17,040 | $8,655 | 50.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 46 | 46 | $17,986 | $7,662 | 42.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 25 | 27 | $10,503 | $4,199 | 40.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 30 | 41 | $8,200 | $3,289 | 40.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 30 | 34 | $5,100 | $2,480 | 48.6% |
About Dr. Lee Hicks, MD
Dr. Lee Hicks, MD is a Hematology & Oncology healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/03/2005. The National Provider Identifier (NPI) number assigned to this provider is 1356342125.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lee Hicks, MD has received a total of $6,076 in payments from pharmaceutical and medical device companies, with $655.35 received in 2024. These payments were reported across 279 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($5,853).
As a Medicare-enrolled provider, Hicks has provided services to 2,144 Medicare beneficiaries, totaling 3,109 services with total Medicare billing of $307,569. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Lexington, KY
- Active Since 08/03/2005
- Last Updated 12/04/2020
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1356342125
Products in Payments
- OPDIVO (Biological) $295.66
- KEYTRUDA (Biological) $279.56
- IMBRUVICA (Drug) $186.85
- Kyprolis (Biological) $183.51
- DARZALEX (Biological) $163.09
- SIR-Spheres Microspheres (Device) $153.50
- GILOTRIF (Drug) $150.45
- Avastin (Biological) $137.48
- CALQUENCE (Drug) $131.59
- LIBTAYO (Biological) $129.60
- JAKAFI (Drug) $124.99
- Erleada (Drug) $124.57
- ONIVYDE (Drug) $121.01
- INJECTAFER (Drug) $116.99
- Abraxane (Drug) $113.87
- ALIYA SYSTEM (Device) $113.12
- Vitrakvi (Drug) $109.06
- Kyprolis (Drug) $109.00
- Revlimid (Drug) $107.45
- KISQALI (Drug) $106.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Lexington
Dr. Nicola Jabbour, M.d, M.D
Hematology & Oncology — Payments: $611,455
Hematology & Oncology $611,455
Dr. Lowell Anthony, M.d, M.D
Hematology & Oncology — Payments: $64,060
Hematology & Oncology $64,060
Dr. Zhonglin Hao, Md, Phd, MD, PHD
Hematology & Oncology — Payments: $22,675
Hematology & Oncology $22,675
John Villano
Hematology & Oncology — Payments: $17,051
Hematology & Oncology $17,051
Dr. Jessica Croley, Md, MD
Hematology & Oncology — Payments: $13,189
Hematology & Oncology $13,189
Mr. Russell Eldridge, Md, MD
Hematology & Oncology — Payments: $10,781
Hematology & Oncology $10,781